Director William H. Rastetter filed a Form 4 with the SEC on November 20, 2026, disclosing the sale of 859 shares of Dare Bioscience, Inc. common stock on November 19, 2026.

Key Highlights

  • Reporting person: William H. Rastetter, identified as a Director of Dare Bioscience, Inc.
  • Transaction: 859 shares of common stock disposed of (transaction code S) on November 19, 2026.
  • Sale price: $0.445 per share, as reported in the filing.
  • Remaining beneficial ownership: 0 shares directly owned following the transaction, according to the filing.
  • Stated purpose: The filing notes the shares were sold "for personal tax planning purposes prior to the end of the calendar year."

Rastetter's November 2026 Common Stock Sale at Dare Bioscience

According to the Form 4 filed with the SEC, William H. Rastetter, a Director of Dare Bioscience, Inc. (NASDAQ:DARE), sold 859 shares of the company's common stock on November 19, 2026, at a price of $0.445 per share. The filing was submitted on November 20, 2026, and was signed by Sabrina Martucci Johnson as attorney-in-fact on Rastetter's behalf.

The filing reports that following the transaction, Rastetter directly beneficially owns 0 shares of Dare Bioscience common stock. The sale is listed under Table I as a disposition (D) of non-derivative securities, with direct (D) ownership form. No derivative securities transactions were reported in Table II of the filing.

In the explanation of responses, the filing states that "these shares were sold by the Reporting Person for personal tax planning purposes prior to the end of the calendar year." The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox on the form was not selected.

What Was Disclosed

Director William H. Rastetter disclosed the sale of 859 shares of Dare Bioscience common stock at $0.445 per share on November 19, 2026, leaving him with zero directly held shares, according to the Form 4 filing.